A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation

Keyphrases

• 3T3 Fibroblasts 20%
• C Substrate 20%
• Carboxy Terminal Domain 20%
• Cell Clones 20%
• Cell Growth 20%
• Cell Morphology 20%
• Cell Transformation 100%
• Chimeric Antigen Receptor T Cells (CAR-T) 20%
• Co-immunoprecipitation (co-IP) 20%
• Complementary DNA (cDNA) 40%
• DNA Synthesis 20%
• EGF Receptor 20%
• Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor Receptor Gene 20%
• ErbB1 20%
• ErbB2 20%
• Ethylnitrosourea 20%
• Glioblastoma 20%
• Human Epidermal Growth Factor Receptor 2 (HER2) 20%
• Hybrid Protein 20%
• Immunofluorescence 20%
• Kinase Activity 20%
• Mammary Carcinoma 20%
• Neu Oncogene 40%
• NIH3T3 40%
• Oncogene 100%
• Protein Kinase 20%
• Receptor-interacting Protein Kinase 1 (RIPK1) 20%
• Soft Agar 20%
• Specific Antibodies 20%
• Transformed Cells 20%
• Transforming Genes 20%
• Transforming Growth Factor-β 20%
• Transgenic Mice 20%
• Transmembrane Kinase 20%
• Tyrosine Kinase 100%
• Tyrosine Phosphorylation 20%

Medicine and Dentistry

• 3T3 Cells 25%
• Agar 12%
• Antibodies 12%
• Breast Carcinoma 12%
• Carboxy Terminal Sequence 12%
• Cell Transformation 100%
• Complementary DNA 25%
• DNA Synthesis 12%
• Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor Receptor 2 100%
• Ethylnitrosourea 12%
• Fibroblast 12%
• Genetic Transfection 12%
• Glioblastoma 12%
• Immunofluorescence 12%
• Immunoprecipitation 12%
• Oncogene 12%
• Oncogene Neu 25%
• Phosphotransferase 12%
• Protein Kinase C 12%
• Protein Phosphorylation 12%
• Protein Tyrosine Kinase 100%
• Proto Oncogene 100%
• Receptor Gene 12%
• Receptor Protein 12%
• Transformed Cell 12%
• Transforming Growth Factor Alpha 12%
• Transgenic Mouse 12%

Biochemistry, Genetics and Molecular Biology

• Antibodies 12%
• Chimeric Protein 12%